Phase I safety and pharmacokinetics trial of MRX I in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 02 Feb 2018
At a glance
- Drugs Contezolid (Primary)
- Indications Methicillin-resistant Staphylococcus aureus infections; Vancomycin-resistant enterococcal infections
- Focus Adverse reactions; First in man; Pharmacokinetics
- 02 Feb 2018 Results assessing safety, tolerability and pharmacokinetics of MRX I in healthy Chinese subjects, were published in the Clinical Therapeutics.
- 24 Apr 2012 Planned initiation date changed to 1 Dec 2010.
- 24 Apr 2012 Status changed from planning to completed.